tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Newamsterdam Pharma Company N.V. (NAMS)
:NAMS
US Market
NAMS
NewAmsterdam Pharma Company
Overview
Analyst Forecasts
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

NewAmsterdam Pharma Company (NAMS) Stock News & Sentiment

Compare
161 Followers
NewAmsterdam Pharma: Buy Rating Backed by Promising Obicetrapib Trials and Strong Financial Position
Premium
Ratings
NewAmsterdam Pharma: Buy Rating Backed by Promising Obicetrapib Trials and Strong Financial Position
8d ago
NAMS
NewAmsterdam Pharma’s 2024 Financial Results and Clinical Progress
Premium
Company Announcements
NewAmsterdam Pharma’s 2024 Financial Results and Clinical Progress
11d ago
NAMS
Newamsterdam Pharma Faces Potential Investor Risks Due to Shareholder Influence
Premium
Company Announcements
Newamsterdam Pharma Faces Potential Investor Risks Due to Shareholder Influence
12d ago
NAMS
Promising Outlook for NewAmsterdam Pharma: Buy Rating Affirmed Amid Successful Trials and Strong Financial Position
Premium
Ratings
Promising Outlook for NewAmsterdam Pharma: Buy Rating Affirmed Amid Successful Trials and Strong Financial Position
13d ago
NAMS
Promising Drug Developments and Positive Trial Results Drive Buy Rating for NewAmsterdam Pharma
Premium
Ratings
Promising Drug Developments and Positive Trial Results Drive Buy Rating for NewAmsterdam Pharma
13d ago
NAMS
NewAmsterdam Pharma Achieves Key Milestones in 2024
Premium
Company Announcements
NewAmsterdam Pharma Achieves Key Milestones in 2024
2M ago
8K
NAMS
NewAmsterdam Pharma’s $452.6M Public Offering Success
Premium
Company Announcements
NewAmsterdam Pharma’s $452.6M Public Offering Success
3M ago
8K
NAMS
More NAMS News >

NAMS News on the Web

NewAmsterdam Pharma Company (NAMS) Receives a Buy from William Blair
TipRanks News
Neutral
Both private equity firms who control a good portion of NewAmsterdam Pharma Company N.V. along with institutions must be dismayed after last week's 8.1% decrease
Yahoo Finance
Neutral
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635
Yahoo Finance
Neutral
NewAmsterdam Pharma to Present at Guggenheim’s SMID Cap Biotech Conference
Yahoo Finance
Neutral
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and NewAmsterdam Pharma Company (NAMS)
TipRanks News
Bullish
Positive Outlook for NewAmsterdam Pharma Driven by Strong Financial Position and Promising Obicetrapib Trial Results
TipRanks News
Bullish
NewAmsterdam Pharma’s $452.6M Public Offering Success
TipRanks News
Bullish
NewAmsterdam Pharma Co NV Announces Pricing of Public Offering
GuruFocus News
Neutral

News Score - Last 7 Days

Neutral
NAMS
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average54%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NAMS’s Media Buzz Sentiment?
Currently, no data Available
What is NAMS’s weekly average amount of articles?
Currently, no data Available
What is NAMS’s News Sentiment?
59% of articles about NAMS were positive this week, compared to its sector average of 54%.
    Healthcare Stocks that are Trending in the News
    OPCHOption Care Health
    JAZZJazz Pharmaceuticals
    CKPTCheckpoint Therapeutics
    PASGPassage Bio
    NVONovo Nordisk
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing